Glenmark Pharmaceuticals receives final approval for Clobetasol Propionate Spray, 0.05%
From USFDA
Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Clobetasol Propionate Spray, 0.05%, the generic version of Clobex1 Spray, 0.05%, of Galderma Laboratories, L.P. This product will be manufactured at Glenmark's Baddi plant in India.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content